Maintenance of Anaesthesia With Sevoflurane Versus Propofol and the Occurrence of Postoperative Headache.
Primary Purpose
Headache
Status
Unknown status
Phase
Not Applicable
Locations
Greece
Study Type
Interventional
Intervention
Propofol
Sevoflurane
Sponsored by
About this trial
This is an interventional prevention trial for Headache
Eligibility Criteria
Inclusion Criteria:
- ASA I-III
- scheduled operation under general anaesthesia
- operations <4 hours
- minorgynaecological operatios (leiomyomectomy)
- hernia repair
- arthroscopic procedurs
- minor orthopaedic operations without the use of tourniquet or cement
- saphenectomy
- minor urologic operations
- minor other operations of general surgery
Exclusion Criteria:
- age <18 and >65 years old
- ASA>III
- Diseases of the central nervous system (ie Parkinsons's disease, Multiple sclerosis, previous ischaemic attack, hydrocephalus, seizure disorder, etc)
- Psychosis under medication
- Cognitive impairement or/and inability to fill in the questionaires
- Allergy or contraindication to the study protocol included drugs
- Operations of more than 4 hours duration
- Head and neck procedures, procedures with neck extension (eg thyroidectomy), ENT procedures
- renal impairement
- hepatic impairement
- patient refusal
Sites / Locations
- 2nd Department of Anesthesiology, Attikon Hospital, 1 Rimini str.Recruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Propofol
Sevoflurane
Arm Description
Total intravenous anaesthesia with propofol for maintainance of anaesthesia.Dose adjusted according to the Bispectral Index (BIS) indication (maintained 40-50). Initial dose 10 mg/kg/h for10 min, 8 mg/kg/h for 10 min and then 6 mg/kg/h).
Sevoflurane for maintainance of anaesthesia. Dose 1 MAC adjusted according to the Bispectral Index (BIS) indication (maintained 40-50).
Outcomes
Primary Outcome Measures
incidence of postoperative headache (yes or no)
Rate of postoperative headache in patients receiving sevoflurane versus propofol (yes or no headache)
Secondary Outcome Measures
Nausea and vomiting
Which anaesthetic (propofol or sevoflurane) is associated with less postoperative nausea and vomiting
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03789370
Brief Title
Maintenance of Anaesthesia With Sevoflurane Versus Propofol and the Occurrence of Postoperative Headache.
Official Title
Maintenance of Anaesthesia With Sevoflurane Versus Propofol and the Occurrence of Postoperative Headache.
Study Type
Interventional
2. Study Status
Record Verification Date
November 2019
Overall Recruitment Status
Unknown status
Study Start Date
November 7, 2014 (Actual)
Primary Completion Date
October 30, 2020 (Anticipated)
Study Completion Date
October 30, 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Attikon Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Postoperative headache is a major issue after general anaesthesia and surgery. The aim of this study is to investigate the possible difference in the occurrence of postoperative headache when general anaesthesia is maintained with propofol, which is supposed to have protective effects on migraine patients, versus sevoflurane.
Detailed Description
Postoperative headache is a major issue after general anaesthesia and surgery. The aim of this study is to investigate the possible difference in the occurrence of postoperative headache when general anaesthesia is maintained with propofol, versus sevoflurane. Propofol acts throught a GABA, and is known to have a therapeutic effect on migraine patients with accute attacts. However, its role on postoperative headache has not been studied, when used for maintainance of anaesthesia, this study aims to investigate the occurrence of headache after anaesthesia and surgery, when patients receive randomly two different anaesthetics: propofol and sevoflurane.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Headache
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Masking Description
The patient and the outcomes assessor will not know what kind of anaesthetic drug was used for maintainance of anaesthesia.
Allocation
Randomized
Enrollment
130 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Propofol
Arm Type
Active Comparator
Arm Description
Total intravenous anaesthesia with propofol for maintainance of anaesthesia.Dose adjusted according to the Bispectral Index (BIS) indication (maintained 40-50). Initial dose 10 mg/kg/h for10 min, 8 mg/kg/h for 10 min and then 6 mg/kg/h).
Arm Title
Sevoflurane
Arm Type
Active Comparator
Arm Description
Sevoflurane for maintainance of anaesthesia. Dose 1 MAC adjusted according to the Bispectral Index (BIS) indication (maintained 40-50).
Intervention Type
Drug
Intervention Name(s)
Propofol
Intervention Description
Maintanance of general anaesthesia with propofol
Intervention Type
Drug
Intervention Name(s)
Sevoflurane
Intervention Description
Maintainance of general anaesthesia with sevoflurane.
Primary Outcome Measure Information:
Title
incidence of postoperative headache (yes or no)
Description
Rate of postoperative headache in patients receiving sevoflurane versus propofol (yes or no headache)
Time Frame
up to 24 hours postoperatively
Secondary Outcome Measure Information:
Title
Nausea and vomiting
Description
Which anaesthetic (propofol or sevoflurane) is associated with less postoperative nausea and vomiting
Time Frame
up to 24 hours postoperatively
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
ASA I-III
scheduled operation under general anaesthesia
operations <4 hours
minorgynaecological operatios (leiomyomectomy)
hernia repair
arthroscopic procedurs
minor orthopaedic operations without the use of tourniquet or cement
saphenectomy
minor urologic operations
minor other operations of general surgery
Exclusion Criteria:
age <18 and >65 years old
ASA>III
Diseases of the central nervous system (ie Parkinsons's disease, Multiple sclerosis, previous ischaemic attack, hydrocephalus, seizure disorder, etc)
Psychosis under medication
Cognitive impairement or/and inability to fill in the questionaires
Allergy or contraindication to the study protocol included drugs
Operations of more than 4 hours duration
Head and neck procedures, procedures with neck extension (eg thyroidectomy), ENT procedures
renal impairement
hepatic impairement
patient refusal
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chrysanthi Batistaki, MD, PhD
Phone
00302105832371
Email
chrysabatistaki@yahoo.gr
First Name & Middle Initial & Last Name or Official Title & Degree
Georgia Kostopanagiotou, MD, PhD
Phone
00302105832371
Email
banesthclin@attikonhospital.gr
Facility Information:
Facility Name
2nd Department of Anesthesiology, Attikon Hospital, 1 Rimini str.
City
Athens
ZIP/Postal Code
12462
Country
Greece
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chrysanthi Batistaki, MD, PhD
Phone
0030 210 5832371
Email
chrysabatistaki@yahoo.gr
12. IPD Sharing Statement
Learn more about this trial
Maintenance of Anaesthesia With Sevoflurane Versus Propofol and the Occurrence of Postoperative Headache.
We'll reach out to this number within 24 hrs